Nuchido time+
Nuchido time+ has been studied in 1 paper since 2024: 1 trial in people. The newest paper, Feb 1, 2024: “The use of a systems approach to increase NAD⁺ in human participants”.
1 paper studies it9 findingsUpdated
See all 1 papers on nuchido time+
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“Two-way, repeated measures ANOVA showed a significant main effect of NT with time on NAD+ concentration (P = 0.007”
None of its findings points the other way.
- 1 lab in 1 country
- Funder: University of Northumbria at Newcastle
- 9 of 9 findings with company ties
- Human trial1
Studies in people
1 study gave nuchido time+ to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
up: Increases NAD+ down: Decreases Interleukin-2 down: Decreases glycated serum protein | Randomized trial28 days | 33 people8 male20–80 yHuman participants | npj aging, Feb 1, 2024 |
What did studies of nuchido time+ find?
8Studies of nuchido time+ measured 8 outcomes, among them biological age, glycated serum protein and pro-inflammatory cytokines.
Biological age
downin humans1
1 study
Biological age
downin humans1
Nuchido time+ decreases biological age in humans (measured by IgG glycosylation profile).
“a shift in the glycosylation profile of immunoglobulin G (IgG) toward a younger biological age”
Human trialmeasured by IgG glycosylation profile
The use of a systems approach to increase NAD⁺ in human participants
npj aging
Glycated serum protein
downin humans1
1 study
Glycated serum protein
downin humans1
Nuchido time+ decreases glycated serum protein in humans.
“a reduction in glycated serum protein”
Human trialserum
The use of a systems approach to increase NAD⁺ in human participants
npj aging
Pro-inflammatory cytokines
downin humans1
1 study
Pro-inflammatory cytokines
downin humans1
Nuchido time+ decreases pro-inflammatory cytokines in humans.
“lower concentrations of pro-inflammatory cytokines in plasma, including a reduction in interleukin 2 (IL2)”
Human trialplasma
The use of a systems approach to increase NAD⁺ in human participants
npj aging
NAD+ concentration in whole blood
upin humans1
1 study
NAD+ concentration in whole blood
upin humans1
Nuchido time+ increases NAD+ concentration in whole blood in humans (double-blind randomized crossover trial).
“the supplement - Nuchido TIME+® (NT) - increased NAD+ concentration in whole blood”
Human trialdouble-blind randomized crossover trialwhole blood
The use of a systems approach to increase NAD⁺ in human participants
npj aging
Interleukin-2
downin humans1
1 study
Interleukin-2
downin humans1
Nuchido time+ decreases Interleukin-2 in humans.
“We also measured a panel of 14 cytokines at baseline and 28 days in the plasma of 16 participants and detected a reduction (P < 0.05) in the mean value compared with baseline in IL2 after 28 days on NT.”
Human trial28 daysn = 16
The use of a systems approach to increase NAD⁺ in human participants
npj aging
NAMPT
upin humans1
1 study
NAMPT
upin humans1
Nuchido time+ increases NAMPT in humans.
“This analysis showed that NT increased SIRT1 significantly (P < 0.05) at 14 and 28 days and increased NAMPT (P < 0.05) at 28 days.”
Human trial28 days
The use of a systems approach to increase NAD⁺ in human participants
npj aging
SIRT1
upin humans1
1 study
SIRT1
upin humans1
Nuchido time+ increases SIRT1 in humans.
“This analysis showed that NT increased SIRT1 significantly (P < 0.05) at 14 and 28 days and increased NAMPT (P < 0.05) at 28 days.”
Human trial28 days
The use of a systems approach to increase NAD⁺ in human participants
npj aging
NAD+
upin humans1
1 study
NAD+
upin humans1
Nuchido time+ increases NAD+ in humans.
“Two-way, repeated measures ANOVA showed a significant main effect of NT with time on NAD+ concentration (P = 0.007”
Human trial28 daysn = 26
The use of a systems approach to increase NAD⁺ in human participants
npj aging
What is nuchido time+ linked with?
1Studies link nuchido time+ with SIRT1.
SIRT1
upin humans1
1 study
SIRT1
upin humans1
Nuchido time+ is associated with SIRT1 in humans.
“This was associated with an increase in SIRT1 and an increase in nicotinamide phosphoribosyltransferase (NAMPT) in peripheral blood mononucleocytes”
Human trialperipheral blood mononuclear cells
The use of a systems approach to increase NAD⁺ in human participants
npj aging